CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,976,580
- in 4 filings, $5.0M under 10b5-1 plans
Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-10 | DAWES KAREN A Director | Sale | −336 | $264.21 | $89K | 92,839 |
| 2021-11-10 | DAWES KAREN A Director | Sale | −488 | $265.27 | $129K | 92,351 |
| 2021-11-10 | DAWES KAREN A Director | Sale | −486 | $266.72 | $130K | 91,865 |
| 2021-11-10 | DAWES KAREN A Director | Sale | −349 | $267.75 | $93K | 91,516 |
| 2021-11-10 | DAWES KAREN A Director | Sale | −255 | $269.94 | $69K | 91,261 |
| 2021-11-10 | DAWES KAREN A Director | Sale | −14 | $271.28 | $4K | 91,247 |
| 2021-11-10 | DAWES KAREN A Director | Exercise or conversion · Stock Option (Right to Buy) | +4,783 | 0 | ||
| 2021-11-04 | RYAN THOMAS F JR Director | Sale | −1,000 | $288.00 | $288K | 12,337 |
| 2021-11-02 | RYAN THOMAS F JR Director | Exercise or conversion | +1,285 | $128.18 | $165K | 14,622 |
| 2021-11-02 | RYAN THOMAS F JR Director | Sale | +1,285 | $302.00 | $388K | 13,337 |
| 2021-11-02 | RYAN THOMAS F JR Director | Exercise or conversion · Stock Option (Right to Buy) | +1,285 | 0 | ||
| 2021-11-02 | DAWES KAREN A Director | Sale | −64 | $299.02 | $19K | 93,583 |
| 2021-11-02 | DAWES KAREN A Director | Sale | −251 | $301.20 | $76K | 93,332 |
| 2021-11-02 | DAWES KAREN A Director | Sale | −446 | $301.97 | $135K | 92,886 |
| 2021-11-02 | DAWES KAREN A Director | Sale | −532 | $303.48 | $161K | 92,354 |
| 2021-11-02 | DAWES KAREN A Director | Sale | −124 | $304.23 | $38K | 92,230 |
| 2021-11-02 | DAWES KAREN A Director | Sale | −700 | $305.91 | $214K | 91,530 |
| 2021-11-02 | DAWES KAREN A Director | Sale | −283 | $306.49 | $87K | 91,247 |
| 2021-10-29 | BARTHELEMY NICOLAS Director | Exercise or conversion | +1,285 | $128.18 | $165K | 3,192 |
| 2021-10-29 | BARTHELEMY NICOLAS Director | Sale | −1,285 | $288.20 | $370K | 1,907 |
Page 24 of 42 · 832 trades